Search Results 1021-1030 of 16344 for monoclonal antibody

  1. Respiratory syncytial virus immune globulin, human (intravenous route) - Mayo Clinic

    RSV-IGIV works by giving your body the antibodies it needs to protect it against RSV infection. RSV infection can cause serious problems, such as pneumonia ...

  2. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    ... monoclonal antibody. History of autoimmune or immune mediated disease prior to enrollment. Subjects with hypothyroidism, diabetes, adrenal insufficiency or ...

  3. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

    Participation eligibility · Received any prior monoclonal antibody against CTLA-4, programmed cell death 1 (PD1) or programmed cell death 1 ligand 1 (PD-L1); ...

  4. Efficacy and Safety of COVID-19 Vaccine in Cancer Patients - Mayo Clinic

    Aims, purpose, or objectives: To determine the antibody response to COVID-19 vaccine after vaccination. To assess the adverse events of COVID-19 vaccines in ...

  5. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

    Prior anti-cancer monoclonal antibody (mAb) for direct anti-neoplastic treatment within 4 weeks prior to study Day 1 or who has not recovered from adverse ...

  6. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Participation eligibility · History of Grade 3 or above hypersensitivity reactions to other monoclonal antibodies. · Subjects with a history of a cardiovascular ...

  7. Overview - T Cell Engineering Laboratory - Mayo Clinic Research

    A chimeric antigen receptor is a synthetic antibody on the surface of T cells that enables T cells to recognize cancer cells. The most successful CAR -T ...

  8. MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question

    The AQP4 antibody, discovered at Mayo Clinic in 2004, was the first biomarker associated with inflammatory demyelinating diseases that could be used to ...

  9. Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

    Tests positive for HIV-1 antibody and HIV-2 antibody, human T-lymphotropic virus 1 antibody, HBs antigen, or HCV antibody. Tests positive for HBs antibody or ...

  10. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dl by protein electrophoresis;; > 200 mg of monoclonal protein in the urine on 24-hour electrophoresis;; If either serum or ...